The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.
OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF
申请人:TREGA BIOSCIENCES, INC.
公开号:EP1126833A2
公开(公告)日:2001-08-29
EP1126833A4
申请人:——
公开号:EP1126833A4
公开(公告)日:2004-09-08
[EN] OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF<br/>[FR] DERIVES OXADIAZOLE, THIADIAZOLE ET TRIAZOLE ET BIBLIOTHEQUES COMBINATOIRES CONTENANT CES DERIVES
申请人:TREGA BIOSCIENCES INC
公开号:WO2000025768A1
公开(公告)日:2000-05-11
The present invention relates to novel compounds of formula (I) wherein X1, X2, X3, X4, T, U and V have the meanings provided. The invention further relates to combinatorial libraries containing at least two or more such compounds, and to methods of preparing combinatorial libraries composed of such compounds.
McClelland; Warren, Journal of the Chemical Society, 1929, p. 2625